drugset / Trial / NCT02513446

Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1026706 in Healthy Male Subjects

NCT02513446

Phase 1 Completed 16 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective of this trial is to investigate the effect of multiple doses of itraconazole on the pharmacokinetics of BI 1026706 given as single dose. The assessment of safety and tolerability of BI 1026706 is an additional objective of this trial. Furthermore, the pharmacokinetics of the metabolite BI 1072668 will be explored.

Timeline

Start
2015-09-29
Primary completion
2015-11-14
Completion
2015-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 1026706 Unknown
Subject Itraconazole Small molecule

Indications

No indication recorded.